Data from Scottish Intercollegiate Guidelines Network (SIGN) - Curated by EPG Health - Last updated 29 May 2018

Status

live

Latest update

01-Aug-16

This guideline covers diagnosis and treatment of colorectal cancer. It summarises the evidence and, where appropriate, provides evidence-based recommendations around: prevention and screening; genetics; referral; diagnosis; surgery; pathology; chemotherapy and radiotherapy; and follow up.

This guideline will be of particular interest to members of the multidisciplinary team treating patients with colorectal cancer (surgeons, oncologists, pathologists, radiologists and nurses), as well as gastroenterologists, general practitioners, patients and their carers.

Read full guideline

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Inflammatory bowel disease assessment tools

Inflammatory bowel disease assessment tools

'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.

Metastatic Melanoma

Metastatic Melanoma

Do you know your ABCDE of melanoma identification? Learn the characteristic signs of malignant skin lesions here.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Load more

Related Content